Press Releases

Read our latest announcements

Filter by year:

2012-11-02
Modus Therapeutics is granted SEK 2.85m for development of sevuparin for the treatment of severe malaria

Modus Therapeutics announces today that it has been granted SEK 2.85m from the Swedish Governmental Agency for Innovation Systems, Vinnova.

View Press Release